BioSpace News Archive

To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center for Gene and Cell Therapy.

Syngenta and the Analytics Society of INFORMS have announced the finalists for the 2019 Syngenta Crop Challenge in Analytics.

Merck KGaA, Darmstadt, Germany and Pfizer Inc. announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance therapy of avelumab in combination with talazoparib,* a poly polymerase inhibitor, versus an active comparator in treatment-naïve patients with locally advanced or metastatic ovarian cancer.

60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria prevention medicine, Kodatef® (tafenoquine succinate).

Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

As red tide devastated marine life and closed beaches on the Florida Gulf Coast, some experienced the impact from the massive algal bloom by way of respiratory ailments and emergency room visits.

Major health and wellness retail buyers at this month’s Weight Management, Sports Nutrition, Vitamin & Hemp Solutions EPPS conference in Orlando will learn all about Bad Ass Cannabis Products and its CBD oil elixirs.

New report from Clarivate Analytics identifies seven new drugs predicted to achieve annual sales of >$1 billion by 2023

Cyxone, a Swedish biotech in autoimmune diseases, announced that preclinical findings support the positioning of its drug candidate T20K as a prophylactic agent for the treatment of multiple sclerosis.

Sciton®, Inc. a leading manufacturer of high-quality laser and light systems in the medical and aesthetic market, announces the HALO™ Distinguished Partner Program.